HIGHLIGHTS
- What: The authors provide an overview of how the mRNA platform works and discuss how lessons learned from the pandemic can inform strategies to enhance trust and facilitate uptake of mRNA-based vaccines and therapeutics beyond COVID-19.
- Who: Shehzad M. Iqbal from the Johns Hopkins University, United States have published the article: Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19, in the Journal: (JOURNAL)
SUMMARY
The novelty of this mode of producing vaccines generated concerns in the public regarding perceived lack of adequate testing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.